| Literature DB >> 36035551 |
Theresa Drallmeier1, Ashley Meyr2.
Abstract
HIV pre-exposure prophylaxis (PrEP) is antiretroviral medication used to prevent HIV in patients at increased risk of acquisition due to sexual practices or intravenous drug use. Despite strong evidence of efficacy and safety, PrEP is currently underutilized in the United States. Initial testing includes HIV, hepatitis B, and renal function. There are currently two oral medications approved for daily use within the U.S.; regular monitoring for HIV and renal dysfunction is required with both medications. Copyright 2022 by the Missouri State Medical Association.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36035551 PMCID: PMC9324708
Source DB: PubMed Journal: Mo Med ISSN: 0026-6620